Arterial hypertension and diabetes developed in pregnancy

Abstract

BACKGROUND: Gestational diabetes mellitus is a significant medical and social problem in most countries. Despite the relatively high level of development of modern medicine, following the growth of obesity and type 2 diabetes, the prevalence of gestational diabetes mellitus is also increasing worldwide.

AIM: To identify the frequency and structure of carbohydrate metabolism disorders and to compare the level of blood pressure in a random sample of pregnant women registered in the Perinatal center.

MATHERIALS AND METHODS: The analysis of the data of examination of carbohydrate metabolism of pregnant women who are registered in the Perinatal Center (Leningrad region, Gatchina), has been carried out. The analysis of medical documentation, survey, endocrinological and gynecological examination, calculation of the body mass index and the study of carbohydrate metabolism have been carried out.

RESULTS: There is an increase in the number of pregnant women with impaired carbohydrate metabolism over the years of observation. Gestational diabetes on diet therapy was 64.4% in 2019, 31.0% — in 2020, 65.1% — in 2021, on insulin therapy — 32.2, 62.3, 28.9% respectively. There was an increase in the number of women with type 1 and type 2 diabetes diagnosed before pregnancy and newly diagnosed diabetes during pregnancy. Body mass index and blood pressure levels are higher and glycated hemoglobin levels are lower in diet-treated pregnant women with gestational diabetes compared with insulin therapy. An increase in glycated hemoglobin was found annually in a group of women with gestational diabetes mellitus on insulin therapy.

CONCLUSIONS: The high prevalence of carbohydrate metabolism disorders and the associated increase in blood pressure in pregnant women in Saint Petersburg and the Leningrad Region justifies a targeted search for carbohydrate metabolism disorders in pregnant women.

Keywords

pregnancy / diabetes mellitus / arterial hypertension

References

[1] Bettikher OA, Zazerskaya IE, Popova PV, Kustarov VN. A comparison of the clinical outcomes of induced and spontaneous labour in patients with gestational diabetes. Diabetes mellitus. 2016;19(2):158–163. (In Russ.). DOI: 10.14341/DM2004130-33

[2] Беттихер О.А., Зазерская И.Е., Попова П.В., Кустаров В.Н. Исходы индуцированных родов у пациенток с гестационным сахарным диабетом // Сахарный диабет. 2016. Т. 19, № 2. С. 158–163. DOI: 10.14341/DM2004130-33

[3] Dedov II, Kolesnikova LI, Bardymova TP, et al. Ethnic specific features of diabetes mellitus in nations of Pribaikalje. The Bulletin of Siberian Branch of Russian Academy of Medical Sciences. 2008;28(1):16–20. (In Russ.)

[4] Дедов И.И., Колесникова Л.И., Бардымова Т.П. и др. Этнические особенности сахарного диабета у народов Прибайкалья // Бюллетень Сибирского отделения Российской академии медицинских наук. 2008. Т. 28, № 1. С. 16–20.

[5] Hajifaraji M, Jahanjou F, Abbasalizadeh F, et al. Effect of probiotic supplements in women with gestational diabetes mellitus on inflammation and oxidative stress biomarkers: a randomized clinical trial. Asia Pac J Clin Nutr. 2018;27(3):581–591. DOI: 10.6133/apjcn.082017.03

[6] Hajifaraji M., Jahanjou F., Abbasalizadeh F. et al. Effect of probiotic supplements in women with gestational diabetes mellitus on inflammation and oxidative stress biomarkers: a randomized clinical trial // Asia Pac. J. Clin. Nutr. 2018. Vol. 27, No. 3. P. 581–591. DOI: 10.6133/apjcn.082017.03

[7] Moyer VA. Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160:414–420. DOI: 10.7326/M13-2905

[8] Moyer V.A. Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement // Ann. Intern. Med. 2014. Vol. 160. P. 414–420. DOI: 10.7326/M13-2905

[9] Peng TY, Ehrlich SF, Crites Y, et al. Trends and racial and ethnic disparities in the prevalence of pregestational type 1 and type 2 diabetes in Northern California: 1996-2014. Am J Obstet Gynecol. 2017;216(2):177.e1–177.e8. DOI: 10.1016/j.ajog.2016.10.007

[10] Peng T.Y., Ehrlich S.F., Crites Y. et al. Trends and racial and ethnic disparities in the prevalence of pregestational type 1 and type 2 diabetes in Northern California: 1996-2014 // Am. J. Obstet. Gynecol. 2017. Vol. 216, No. 2. P. 177.e1–177.e8. DOI: 10.1016/j.ajog.2016.10.007

[11] Hagiwara Y, Kasai J, Nakanishi S, et al. Should the IADPSG criteria be applied when diagnosing early-onset gestational diabetes? Diabetes Res Clin Pract. 2018;140:154–161. DOI: 10.1016/j.diabres.2018.03.048

[12] Hagiwara Y., Kasai J., Nakanishi S. et al. Should the IADPSG criteria be applied when diagnosing early-onset gestational diabetes? // Diabetes Res. Clin. Pract. 2018. Vol. 140. P. 154–161. DOI: 10.1016/j.diabres.2018.03.048

[13] American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33 Suppl 1(Suppl 1):S62–69. DOI: 10.2337/dc10-S062

[14] American Diabetes Association. Diagnosis and classification of diabetes mellitus // Diabetes Care. 2010. Vol. 33 Suppl 1, No. Suppl 1. P. S62–69. DOI: 10.2337/dc10-S062

[15] Endocrinology: national guidelines. Ed. by I.I. Dedov, G.A. Melnichenko. Мoscow: GEHOTAR-Media; 2008. (In Russ.)

[16] Эндокринология: национальное руководство / под ред. И.И. Дедова, Г.А. Мельниченко. М.: ГЭОТАР-Медиа, 2008.

[17] Flack JR, Ross GP. Survey on testing for gestational diabetes mellitus in Australia. Aust N Z J Obstet Gynaecol. 2016;56(4):346–348. DOI: 10.1111/ajo.12457

[18] Flack J.R., Ross G.P. Survey on testing for gestational diabetes mellitus in Australia // Aust. NZ J. Obstet. Gynaecol. 2016. Vol. 56, No. 4. P. 346–348. DOI: 10.1111/ajo.12457

[19] Wu ET, Nien FJ, Kuo CH, et al. Diagnosis of more gestational diabetes lead to better pregnancy outcomes: Comparing the International Association of the Diabetes and Pregnancy Study Group criteria, and the Carpenterand Coustan criteria. J Diabetes Investig. 2016;7(1):121–126. DOI: 10.1111/jdi.12378

[20] Wu E.T., Nien F.J., Kuo C.H. et al. Diagnosis of more gestational diabetes lead to better pregnancy outcomes: Comparing the International Association of the Diabetes and Pregnancy Study Group criteria, and the Carpenterand Coustan criteria // J. Diabetes Investig. 2016. Vol. 7, No. 1. P. 121–126. DOI: 10.1111/jdi.12378

[21] Dedov II, Kolesnikova LI, Ivanova ON, et al. Polimorfizm genov HLA klassa II i CTLA4 zdorovykh buryat i bol’nykh sakharnym diabetom 1 tipa v Buryatskoj Respublike. Diabetes mellitus. 2006;(1):2–8. (In Russ.). DOI: 10.14341/2072-0351-5373

[22] Дедов И.И., Колесникова Л.И., Иванова О.Н. и др. Полиморфизм генов HLA класса II и CTLA4 здоровых бурят и больных сахарным диабетом 1 типа в Бурятской Республике // Сахарный диабет. 2006. № 1. С. 2–8. DOI: 10.14341/2072-0351-5373

[23] Lavery JA, Friedman AM, Keyes KM, et al. Gestational diabetes in the United States: temporal changes in prevalence rates between 1979 and 2010. BJOG. 2017;124(5):804–813. DOI: 10.1111/1471-0528.14236

[24] Lavery J.A., Friedman A.M., Keyes K.M. et al. Gestational diabetes in the United States: temporal changes in prevalence rates between 1979 and 2010 // BJOG. 2017. Vol. 124, No. 5. P. 804–813. DOI: 10.1111/1471-0528.14236

[25] Zaman F, Nouhjah S, Shahbazian H, et al. Risk factors of gestational diabetes mellitus using results of a prospective population-based study in Iranian pregnant women. Diabetes Metab Syndr. 2018;12(5):721–725. DOI: 10.1016/j.dsx.2018.04.014

[26] Zaman F., Nouhjah S., Shahbazian H. et al. Risk factors of gestational diabetes mellitus using results of a prospective population-based study in Iranian pregnant women // Diabetes Metab. Syndr. 2018. Vol. 12, No. 5. P. 721–725. DOI: 10.1016/j.dsx.2018.04.014

[27] Xiao Y, Chen R, Chen M, et al. Age at menarche and risks of gestational diabetes mellitus: a meta-analysis of prospective studies. Oncotarget. 2017;9(24):17133–17140. DOI: 10.18632/oncotarget.23658

[28] Xiao Y., Chen R., Chen M. et al. Age at menarche and risks of gestational diabetes mellitus: a meta-analysis of prospective studies // Oncotarget. 2017. Vol. 9, No. 24. P. 17133–17140. DOI: 10.18632/oncotarget.23658

[29] Lizneva D, Suturina L, Walker W, et al. Criteria, prevalence and phenotypes of polycystic ovary syndrome. Fertil Steril. 2016;106(1):6–15. DOI: 10.1016/j.fertnstert.2016.05.003

[30] Lizneva D., Suturina L., Walker W. et al. Criteria, prevalence and phenotypes of polycystic ovary syndrome // Fertil. Steril. 2016. Vol. 106, No. 1. P. 6–15. DOI: 10.1016/j.fertnstert.2016.05.003

[31] Buckley BS, Harreiter J, Damm P, et al. Gestational diabetes mellitus in Europe: prevalence, current screening practice and barriers to screening. A review. Diabet Med. 2012;29(7):844–854. DOI: 10.1111/j.1464-5491.2011.03541.x

[32] Buckley B.S., Harreiter J., Damm P. et al. Gestational diabetes mellitus in Europe: prevalence, current screening practice and barriers to screening. A review // Diabet. Med. 2012. Vol. 29, No. 7. P. 844–854. DOI: 10.1111/j.1464-5491.2011.03541.x

[33] McGuane JT, Grlj L, Peek MJ. Obesity, gestational diabetes and macrosomia are associated with increasing rates of early-term induction of labour at The Canberra Hospital. Aust N Z J Obstet Gynaecol. 2019;59(2):215–220. DOI: 10.1111/ajo.12820

[34] McGuane J.T., Grlj L., Peek M.J. Obesity, gestational diabetes and macrosomia are associated with increasing rates of early-term induction of labour at The Canberra Hospital // Aust. NZ J. Obstet. Gynaecol. 2019. Vol. 59, No. 2. P. 215–220. DOI: 10.1111/ajo.12820

[35] Lima RJCP, Batista RFL, Ribeiro MRC, et al. Prepregnancy body mass index, gestational weight gain, and birth weight in the BRISA cohort. Rev Saude Publica. 2018;52:46. DOI: 10.11606/s1518-8787.2018052000125

[36] Lima R.J.C.P., Batista R.F.L., Ribeiro M.R.C. et al. Prepregnancy body mass index, gestational weight gain, and birth weight in the BRISA cohort // Rev. Saude Publica. 2018. Vol. 52. P. 46. DOI: 10.11606/s1518-8787.2018052000125

[37] International Weight Management in Pregnancy (i-WIP) Collaborative Group. Effect of diet and physical activity based interventions in pregnancy on gestational weight gain and pregnancy outcomes: meta-analysis of individual participant data from randomised trials. BMJ. 2017;358:j3119. DOI: 10.1136/bmj.j3119

[38] International Weight Management in Pregnancy (i-WIP) Collaborative Group. Effect of diet and physical activity based interventions in pregnancy on gestational weight gain and pregnancy outcomes: meta-analysis of individual participant data from randomised trials // BMJ. 2017. Vol. 358. P. j3119. DOI: 10.1136/bmj.j3119

[39] Meinilä J, Valkama A, Koivusalo SB, et al. Association between diet quality measured by the Healthy Food Intake Index and later risk of gestational diabetes-a secondary analysis of the RADIEL trial. Eur J Clin Nutr. 2017;71(7):913. DOI: 10.1038/ejcn.2017.66

[40] Meinilä J., Valkama A., Koivusalo S.B. et al. Association between diet quality measured by the Healthy Food Intake Index and later risk of gestational diabetes-a secondary analysis of the RADIEL trial // Eur. J. Clin. Nutr. 2017. Vol. 71, No. 7. P. 913. DOI: 10.1038/ejcn.2017.66

[41] Valkama AJ, Meinilä J, Koivusalo S, et al. The effect of pre-pregnancy lifestyle counselling on food intakes and association between food intakes and gestational diabetes in high-risk women: results from a randomised controlled trial. J Hum Nutr Diet. 2018;31(3):301–305. DOI: 10.1111/jhn.12547

[42] Valkama A.J., Meinilä J., Koivusalo S. et al. The effect of pre-pregnancy lifestyle counselling on food intakes and association between food intakes and gestational diabetes in high-risk women: results from a randomised controlled trial // J. Hum. Nutr. Diet. 2018. Vol. 31, No. 3. P. 301–305. DOI: 10.1111/jhn.12547

[43] Michalakis K, Mintziori G, Kaprara A, et al. The complex interaction between obesity, metabolic syndrome and reproductive axis: A narrative review. Metabolism. 2013;62(4):457–478. DOI: 10.1016/j.metabol.2012.08.012

[44] Michalakis K., Mintziori G., Kaprara A. et al. The complex interaction between obesity, metabolic syndrome and reproductive axis: A narrative review // Metabolism. 2013. Vol. 62, No. 4. P. 457–478. DOI: 10.1016/j.metabol.2012.08.012

[45] Petunina NA, Kuzina IA. The role of hormones of adipose tissue in the development pregnancy complications in obese women. Obesity and metabolism. 2013;10(1):3–8. (In Russ.). DOI: 10.14341/2071-8713-5063

[46] Петунина Н.А., Кузина И.А. Роль гормонов жировой ткани в развитии осложнений беременности у женщин с ожирением // Ожирение и метаболизм. 2013. Т. 10, № 1. С. 3–8. DOI: 10.14341/2071-8713-5063

[47] Lobo TF, Torloni MR, Mattar R, et al. Adipokine levels in overweight women with early-onset gestational diabetes mellitus. J Endocrinol Invest. 2019;42(2):149–156. DOI: 10.1007/s40618-018-0894-0

[48] Lobo T.F., Torloni M.R., Mattar R. et al. Adipokine levels in overweight women with early-onset gestational diabetes mellitus // J. Endocrinol. Invest. 2019. Vol. 42, No. 2. P. 149–156. DOI: 10.1007/s40618-018-0894-0

[49] Nanda S, Yu CKH, Giurcaneanu L, et al. Maternal Serum Adiponectin at 11–13 weeks of gestation in preeclampsia. Fetal Diagn Ther. 2011;29(3):208–215. DOI: 10.1159/000322402

[50] Nanda S., Yu C.K.H., Giurcaneanu L. et al. Maternal serum adiponectin at 11–13 weeks of gestation in preeclampsia // Fetal. Diagn. Ther. 2011. Vol. 29, No. 3. P. 208–215. DOI: 10.1159/000322402

[51] Parlea L, Bromberg IL, Feig DS, et al. Association between serum 25-hydroxyvitamin D in early pregnancy and risk of gestational diabetes mellitus. Diabet Med. 2012;29(7):e25–32. DOI: 10.1111/j.1464-5491.2011.03550.x

[52] Parlea L., Bromberg I.L., Feig D.S. et al. Association between serum 25-hydroxyvitamin D in early pregnancy and risk of gestational diabetes mellitus // Diabet. Med. 2012. Vol. 29, No. 7. P. 25–32. DOI: 10.1111/j.1464-5491.2011.03550.x

[53] Ruyatkina LA, Sorokin MY. Detemir potential applications in the treatment of diabetes during pregnancy: proven benefits and perspectives. Diabetes mellitus. 2016;19(2):171–178. DOI: 10.14341/DM2004150-55

[54] Руяткина Л.А., Сорокин М.Ю. Возможности применения инсулина детемир при лечении сахарного диабета у беременных: доказанные преимущества и перспективы использования // Сахарный диабет. 2016. Т. 19, № 2. С. 171–178. DOI: 10.14341/DM2004150-55

[55] Kapustin RV, Arzhanova ON, Tisel’ko AV. Oxidative stress in pregnant women with diabetes mellitus. Diabetes mellitus. 2017;20(6):461–471. (In Russ.). DOI: 10.14341/DM8669

[56] Капустин Р.В., Аржанова О.Н., Тиселько А.В. Оксидативный стресс у беременных с сахарным диабетом // Сахарный диабет. 2017. Т. 20, № 6. С. 461–471. DOI: 10.14341/DM8669

[57] Kolesnikova LI, Grebenkina LA, Darenskaya MA, Vlasov BYa. Oxidative stress as nonspecific pathogenetic link of reproductive disorders (systematic review). The Bulletin of Siberian Branch of Russian Academy of Medical Sciences. 2012;32(1):58–66. (In Russ.)

[58] Колесникова Л.И., Гребенкина Л.А., Даренская М.А., Власов Б.Я. Окислительный стресс как неспецифическое патогенетическое звено репродуктивных нарушений (обзор) // Бюллетень Сибирского отделения Российской академии медицинских наук. 2012. Т. 32, № 1. С. 58–66.

[59] Kolesnikova LI, Osipova EV, Grebenkina LA. Okislitel’nyj stress pri reproduktivnykh narusheniyakh ehndokrinnogo geneza u zhenshhin. Novosibirsk; 2011. (In Russ.)

[60] Колесникова Л.И., Осипова Е.В., Гребенкина Л.А. Окислительный стресс при репродуктивных нарушениях эндокринного генеза у женщин. Новосибирск, 2011.

[61] Cundy T, Gamble G, Townend K, et al. Perinatal mortality in Type 2 diabetes mellitus. Diabet Med. 2000;17(1):33–39. DOI: 10.1046/j.1464-5491.2000.00215.x

[62] Cundy T., Gamble G., Townend K. et al. Perinatal mortality in Type 2 diabetes mellitus // Diabet. Med. 2000. Vol. 17, No. 1. P. 33–39. DOI: 10.1046/j.1464-5491.2000.00215.x

[63] Li X, Zhang W, Lin J, et al. Risk factors for adverse maternal and perinatal outcomes in women with preeclampsia: analysis of 1396 cases. J Clin Hypertens (Greenwich). 2018;20(6):1049–1057. DOI: 10.1111/jch.13302

[64] Li X., Zhang W., Lin J. et al. Risk factors for adverse maternal and perinatal outcomes in women with preeclampsia: analysis of 1396 cases // J. Clin. Hypertens (Greenwich). 2018. Vol. 20, No. 6. P. 1049–1057. DOI: 10.1111/jch.13302

[65] Baliutavičienė D, Buinauskienė JB, Petrenko V, et al. Gestational diabetes, obesity, and metabolic syndrome diagnosed during pregnancy. Metab Syndr Relat Disord. 2012;10(3):214–217. DOI: 10.1089/met.2011.0067

[66] Baliutavičienė D., Buinauskienė J.B., Petrenko V. et al. Gestational diabetes, obesity, and metabolic syndrome diagnosed during pregnancy // Metab. Syndr. Relat. Disord. 2012. Vol. 10, No. 3. P. 214–217. DOI: 10.1089/met.2011.0067

[67] Sacks DA. The use of pharmacotherapy in pregnancies with suspected diabetic fetopathy. J Matern Fetal Neonatal Med. 2012;25(1):45–49. DOI: 10.3109/14767058.2012.626929

[68] Sacks D.A. The use of pharmacotherapy in pregnancies with suspected diabetic fetopathy // J. Matern. Fetal. Neonatal. Med. 2012. Vol. 25, No. 1. P. 45–49. DOI: 10.3109/14767058.2012.626929

[69] Desoye G, Nolan CJ. The fetal glucose steal: an underappreciated phenomenon in diabetic pregnancy. Diabetologia. 2016;59(6):1089–1094. DOI: 10.1007/s00125-016-3931-6

[70] Desoye G., Nolan C.J. The fetal glucose steal: an underappreciated phenomenon in diabetic pregnancy // Diabetologia. 2016. Vol. 59, No. 6. P. 1089–1094. DOI: 10.1007/s00125-016-3931-6

[71] Esakoff TF, Cheng YW, Sparks TN, Caughey AB. The association between birthweight 4000 g or greater and perinatal outcomes in patients with and without gestational diabetes mellitus. Am J Obstet Gynecol. 2009;200(6):672.e1–4. DOI: 10.1016/j.ajog.2009.02.035

[72] Esakoff T.F., Cheng Y.W., Sparks T.N., Caughey A.B. The association between birthweight 4000 g or greater and perinatal outcomes in patients with and without gestational diabetes mellitus // Am. J. Obstet. Gynecol. 2009. Vol. 200, No. 6. P. 672.e1–4. DOI: 10.1016/j.ajog.2009.02.035

[73] Li J, Qian G, Zhong X, Yu T. Insulin treatment cannot promote lipogenesis in rat fetal lung in gestational diabetes mellitus because of failure to redress the imbalance among SREBP-1, SCAP, and INSIG-1. DNA Cell Biol. 2018;37(3):264–270. DOI: 10.1089/dna.2017.3906

[74] Li J., Qian G., Zhong X., Yu T. Insulin treatment cannot promote lipogenesis in rat fetal lung in gestational diabetes mellitus because of failure to redress the imbalance among SREBP-1, SCAP, and INSIG-1 // DNA Cell. Biol. 2018. Vol. 37, No. 3. P. 264–270. DOI: 10.1089/dna.2017.3906

[75] Mikhalev EV, Shanina OM, Saprina TV. Hormonal, electrolyte disturbances and features of hemostasis in term newborn infants of mothers with gestational diabetes mellitus. Diabetes mellitus. 2015;18(1):78–86. (In Russ.). DOI: 10.14341/DM2015178-86

[76] Михалев Е.В., Шанина О.М., Саприна Т.В. Гормональные, электролитные нарушения и особенности гемостаза у доношенных новорожденных детей от матерей с гестационным сахарным диабетом // Сахарный диабет. 2015. Т. 18, № 1. С. 78–86. DOI: 10.14341/DM2015178-86

[77] Chabanova NB, Mataev SI, Vasil’kova T, Troshina IA. Metabolic disorders in adipocytokine imbalance and gestational complications. Obesity and metabolism. 2017;14(1):9–16. (In Russ.). DOI: 10.14341/OMET201719-16

[78] Чабанова Н.Б., Матаев С.И., Василькова Т.Н., Трошина И.А. Метаболические нарушения при адипоцитокиновом дисбалансе и гестационные осложнения. // Ожирение и метаболизм. 2017. Т. 14, №. 1. С. 9–16. DOI: 10.14341/OMET201719-16

[79] McLachlan KA, O’Neal D, Jenkins A, Alford FP. Do adiponectin, TNFα, leptin and CRP relate to insulin resistance in pregnancy? Studies in women with and without gestational diabetes, during and after pregnancy. Diabetes Metab Res Rev. 2006;22(2):131–138. DOI: 10.1002/dmrr.591

[80] McLachlan K.A., O’Neal D., Jenkins A., Alford F.P. Do adiponectin, TNFα, leptin and CRP relate to insulin resistance in pregnancy? Studies in women with and without gestational diabetes, during and after pregnancy // Diabetes Metab. Res. Rev. 2006. Vol. 22, No. 2. P. 131–138. DOI: 10.1002/dmrr.591

[81] Agarwal MM, Punnose J, Sukhija K, et al. Gestational diabetes mellitus: Using the fasting plasma glucose level to simplify the International Association of Diabetes and Pregnancy Study Groups Diagnostic Algorithm in an adult South Asian population. Can J Diabetes. 2018;42(5):500–504. DOI: 10.1016/j.jcjd.2017.12.009

[82] Agarwal M.M., Punnose J., Sukhija K. et al. Gestational diabetes mellitus: Using the fasting plasma glucose level to simplify the International Association of Diabetes and Pregnancy Study Groups Diagnostic Algorithm in an adult South Asian population // Can. J. Diabetes. 2018. Vol. 42, No. 5. P. 500–504. DOI: 10.1016/j.jcjd.2017.12.009

[83] Abdrakhmanova AI, Oslopova YuV, Khasanova RN, Tsibul’kin NA. Arterial’naya gipertenziya u beremennykh: uchebnoe posobie. Kazan’; 2017. (In Russ.)

[84] Абдрахманова А.И., Ослопова Ю.В., Хасанова Р.Н., Цибулькин Н.А. Артериальная гипертензия у беременных: учебное пособие. Казань, 2017.

[85] Wang L, Leng J, Liu H, et al. Association between hypertensive disorders of pregnancy and the risk of postpartum hypertension: a cohort study in women with gestational diabetes. J Hum Hypertens. 2017;31(11):725–730. DOI: 10.1038/jhh.2017.46

[86] Wang L., Leng J., Liu H. et al. Association between hypertensive disorders of pregnancy and the risk of postpartum hypertension: a cohort study in women with gestational diabetes // J. Hum. Hypertens. 2017. Vol. 31, No. 11. P. 725–730. DOI: 10.1038/jhh.2017.46

[87] Sathish T, Kapoor N, Cao Y, et al. Proportion of newly diagnosed diabetes in COVID-19 patients: A systematic review and meta-analysis. Diabetes Obes Metab. 2021;23(3):870–874. DOI: 10.1111/dom.14269

[88] Sathish T., Kapoor N., Cao Y. et al. Proportion of newly diagnosed diabetes in COVID-19 patients: A systematic review and meta-analysis // Diabetes Obes. Metab. 2021. Vol. 23, No. 3. P. 870–874. DOI: 10.1111/dom.14269

[89] Standards of specialized diabetes care. Ed. by I.I. Dedov, M.V. Shestakova, A.Yu. Mayorov. 10th edition. Moscow; 2021. (In Russ.). DOI: 10.14341/DM12802

[90] Алгоритмы специализированной медицинской помощи больным сахарным диабетом / под ред. И.И. Дедова, М.В. Шестаковой, А.Ю. Майорова. 10-й выпуск (дополненный). М., 2021. DOI: 10.14341/DM12802

RIGHTS & PERMISSIONS

Zagarskikh E.Y., Partsernyak S.A., Rishchuk S.V., Proshchai G.A.